Abstract:Sepsis is defined as a life-threatening organ failure due to dysregulated host response to infection. Despite current advances in our knowledge about sepsis, it is still considered as a major global health challenge. Myocardial dysfunction is a well-defined manifestation of sepsis which is related to worse outcomes in septic patients. Given that the heart is a mitochondria-rich organ and the normal function of mitochondria is essential for successful modulation of septic response, the contribution of mitochondrial damage in sepsis-related myocardial dysfunction has attracted the attention of many scientists. It is widely accepted that mitochondrial damage is involved in sepsis-related myocardial dysfunction; however, effective and potential treatment modalities in clinical setting are still lacking. Mitochondrial-based therapies are potential approaches in sepsis treatment. Although various therapeutic strategies have been used for mitochondrial function improvement, their effects are limited when mitochondria undergo irreversible alterations under septic challenge. Therefore, application of more effective approaches such as mitochondrial transplantation has been suggested. This review highlights the crucial role of mitochondrial damage in sepsis-related myocardial dysfunction, then provides an overview on mitochondrial-based therapies and current approaches to mitochondrial transplantation as a novel strategy, and proposes future directions for more researches in this field.

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria

Mitochondrial dysfunction and acute renal injury in sepsis

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

Mitochondrial dysfunction and resuscitation in sepsis

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

The pathogenesis and potential therapeutic targets in sepsis

Mitochondrial Damage in Sepsis

Identification of biomarkers and pathways of mitochondria in sepsis patients

Targeting ferroptosis in the maintenance of mitochondrial homeostasis in the realm of septic cardiomyopathy

Mitochondria-Derived Damage-Associated Molecular Patterns In Sepsis: From Bench To Bedside